Locations:
SearchAdvertisement
Retrospective study aims to better stratify risk of disease recurrence
Majority of 1,000 patients seen in 2022 discharged home
Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Timely referral to hospice care reduces emergency room admissions
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The retrospective study identifies factors that influence disease-free and overall survival
62% of patients were progression-free at 18 months post-transplantation
Focused ultrasound is paired with ALA to utilize sonodynamic therapy to target cancer cells
Study assesses the impact of donor source and post-transplant prophylaxis for patients receiving a hematopoietic cell transplant
Reassessing antibiotic dosage and type and restoring gut biome could improve survival rates
Immunotherapy is preferred initial treatment for majority of patients
Advertisement
Advertisement